PRCC Rabbit Polyclonal Antibody

This gene encodes a protein that may play a role in pre-mRNA splicing. Chromosomal translocations (X;1)(p11;q21) that result in fusion of this gene to TFE3 (GeneID 7030) have been associated with papillary renal cell carcinoma. A PRCC-TFE3 fusion protein is expressed in affected carcinomas and is likely associated with altered gene transactivation. This fusion protein has also been associated with disruption of the cell cycle.

The PRCC Rabbit Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of PRCC protein expression. This antibody has been meticulously developed and rigorously validated to ensure exceptional performance in various applications, including immunohistochemistry, western blotting, and immunofluorescence.

The PRCC Rabbit Polyclonal Antibody exhibits exceptional sensitivity and specificity, enabling accurate and precise detection of PRCC protein in a wide range of sample types. It has been extensively tested and validated against a variety of cell lines and tissues, ensuring consistent and reproducible results.

This antibody is produced using state-of-the-art recombinant technology, ensuring high purity and batch-to-batch consistency. It is manufactured under strict quality control standards to guarantee optimal performance and reliability. The PRCC Rabbit Polyclonal Antibody is supplied in a convenient and user-friendly format, allowing for easy handling and storage.

With its exceptional performance characteristics, the PRCC Rabbit Polyclonal Antibody is an indispensable tool for researchers and clinicians involved in cancer research, particularly in the study of PRCC-related malignancies. Its reliable and accurate detection capabilities make it an invaluable asset in understanding the role of PRCC protein in disease progression and therapeutic interventions.

Choose the PRCC Rabbit Polyclonal Antibody for its exceptional quality, reliability, and performance, and unlock new insights into the intricate mechanisms underlying PRCC-related diseases.